Harnessing network biology to improve drug discovery

Details for Australian Patent Application No. 2005309649 (hide)

Owner Odyssey Thera, Inc.

Inventors Lamerdin, Jane; Westwick, John K.; Michnick, Stephen W.; Keon, Brigitte; MacDonald, Marnie L.

Agent Allens Arthur Robinson

Pub. Number AU-A-2005309649

PCT Pub. Number WO2006/058014

Priority 11/282,745 21.11.05 US; 60/629,558 22.11.04 US

Filing date 22 November 2005

Wipo publication date 1 June 2006

International Classifications

G06F 19/00 (2006.01) Digital computing or data processing equipment or methods, specially adapted for specific applications

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

Event Publications

28 June 2007 PCT application entered the National Phase

  PCT publication WO2006/058014 Priority application(s): WO2006/058014

13 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005309651-Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin

2005309647-Gonadotropin Releasing Hormone receptor antagonists